Sodium Erythorbate.

Erythorbate is the stereoisomer of ascorbate and shares its reducing power, holding dietary non-heme iron in the ferrous state at intestinal pH. That is the form the DMT1 transporter carries, so iron uptake from a plant-source formula rises when a reductant sits alongside it.

Ferrous salts oxidise readily in a moist powder or a liquid, and a reducing agent such as erythorbate takes the oxidative hit first. Long-standing formulation practice pairs the two so the iron stays in the ferrous state through shelf life.

Erythorbic acid is close enough in shape to ascorbate that the sodium-dependent vitamin C transporters carry it, and the two compete for the same sites. Large intakes of erythorbate can lower the amount of true ascorbate that tissues take up and retain.

Erythorbate carries the same reducing chemistry as vitamin C but almost none of its vitamin activity in the body, and it competes with ascorbate for uptake. A label that leans on erythorbate for antioxidant duty is not thereby contributing vitamin C.

Tocopherols work inside the fat phase and are left as a tocopheroxyl radical after they act, while erythorbate sits in the water phase and can hand an electron back across the interface. The pairing is standard practice in oil-containing formats to slow the oxidation of the fat.

Tocopherol intercepts lipid radicals inside the fat phase and becomes a tocopheroxyl radical; erythorbate in the water phase reduces it back. The same regeneration chemistry that ascorbate performs applies here because the redox centre of the two isomers is identical. This is why the two are combined in oil-containing foods.

Erythorbate donates an electron to the tocopheroxyl radical at the oil and water interface, returning the tocopherol to its active form. The stereochemistry that reduces erythorbate's vitamin activity in the body does not change this redox reaction. Read it as chemistry in the product, not as a nutritional effect.

Rosemary extract supplies carnosic acid and carnosol, which are lipid-phase phenolics, while erythorbate works from the aqueous phase and can regenerate their oxidised forms. The two are combined in meat and oil systems for that reason. The evidence is from food chemistry and shelf-life work.

Mixed tocopherols scavenge peroxyl radicals in the lipid phase and are regenerated at the interface by a water-soluble reductant such as erythorbate. Neither antioxidant covers both phases alone. The combination is routine in oil and emulsion formulation.

Trace iron and copper catalyse the very oxidation reactions erythorbate is added to slow, and a reducing agent alone can make matters worse by keeping those metals in their more reactive lower valence state. Citrate binds the metals so the reduction chemistry does not turn into a catalytic cycle. Pairing a sequestrant with a reductant is standard antioxidant system design.

Erythorbate reduces cupric copper to the cuprous form, which reacts with peroxides to generate radicals, so an unchelated copper trace can flip a reducing agent into a pro-oxidant. The same is true in the other direction with iron. It is why chelators accompany reducing agents in oxidation-prone formulas.

Erythorbate can complex divalent metals in solution the way ascorbate does, which affects the free ion concentration in a formula. Zinc is not redox active in the Fenton sense, so the pro-oxidant concern does not apply here. The interaction is about speciation in the product.

Erythorbate reduces the quercetin phenoxyl radical back to the parent flavonoid, extending its useful life in an aqueous system. Because erythorbate is cheap and highly reducing, it is used where the vitamin activity of ascorbate is not required. Chemistry in the formula, not a combined effect in people.

Carotenoids bleach as they oxidise, and a water-soluble reductant at the interface slows that loss in an emulsion. Erythorbate is used for colour protection on exactly this basis in food systems. The endpoint measured is pigment retention.

Lycopene oxidises and loses colour readily in processed products, and a reducing agent in the water phase slows the onset. Erythorbate is one of the reductants used for this. The measure is pigment stability rather than any effect in a person.

Catechins oxidise and brown in neutral aqueous solution, and an added reductant delays that visible change. Erythorbate performs this role where vitamin C activity is not being claimed on the label. Formulation chemistry.